admin

admin

Mesenchymal Stem Cell (MSC) Therapy for Parkinson’s Disease Premotor Symptoms

Introduction Parkinson’s Disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms (tremor, rigidity, bradykinesia) and non-motor or premotor symptoms (NMS) such as depression, anxiety, sleep disturbances, and cognitive decline. These non-motor manifestations often appear years before classical motor signs, indicating a prolonged…

Multiple Sclerosis Treatment using Stem Cells

Stem cell therapy has emerged as a promising field in the treatment of multiple sclerosis (MS), aiming to repair or replace cells in the central nervous system affected by the disease. This overview summarizes current research and developments in the…

MSC Secretome as a Regenerative Strategy for Parkinson’s Disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that leads to tremor, rigidity, slowness of movement, and postural instability. The disease primarily results from the loss of dopaminergic neurons in the substantia nigra and widespread neuroinflammation. While conventional medications such as levodopa can relieve symptoms, they…

A New Path to Pigmentation Correction UC-MSC Therapy in Thailand

Skin pigmentation disorders—including vitiligo, melasma, sun spots, freckles, and post-inflammatory hyperpigmentation—affect a large portion of the global population and often have a significant impact on appearance and confidence. These conditions arise from imbalances in melanin, the pigment that gives skin…

Stem Cell Therapy: A Transformative Approach to Diabetes Management

Stem cell therapy is increasingly regarded as a groundbreaking development in the treatment of diabetes, particularly Type 1 diabetes mellitus. This condition results from the immune system mistakenly attacking and eliminating the insulin-producing beta cells in the pancreas. While conventional treatment strategies, such…

This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.

Accept All Accept Required Only